News

Filter

Current filters:

Aptivus

1 to 9 of 37 results

Aptivus achieves SVR in treatment-experienced children

18-08-2008

At the 2008 International AIDS Conference, in Mexico City, Boehringer Ingelheim presented new 100-week…

AptivusBoehringer IngelheimNystatinOralTipranavir

Aptivus gives durable response in HIV patients

05-11-2007

German drug major Boehringer Igelheim says that new data from the combined RESIST-1 and RESIST-2 studies…

AptivusEnfuvirtideFuzeonNorvirOral SolutionRitonavir CapsulesTipranavir

Strong female-specific data for Aptivus

06-08-2007

At the International AIDS Society congress, held in Sydney, Australia, German drug major Boehringer Ingelheim…

AptivusBoehringer IngelheimEnfuvirtideFuzeonTipranavir

Boeh Ing initiates Ph IIIb Aptivus study

25-06-2007

German drugmaker Boehringer Ingelheim says that it has begun enrolling patients in a Phase IIIb study…

AptivusBoehringer IngelheimTipranavir

Aptivus resistant HIV still responds to darunavir

12-03-2007

German drugmaker Boehringer Ingelheim says that development of V82L or T protease mutations following…

AptivusBoehringer IngelheimDarunavirPrezistaTipranavir

Promising long-term data for Boehringer's Aptivus

20-11-2006

German drugmaker Boehringer Ingelheim presented encouraging new data at the 8th International Congress…

AptivusBoehringer IngelheimTipranavir

1 to 9 of 37 results

COMPANY SPOTLIGHT

Menarini

Back to top